Table 1.

Tumor-to-Muscle (T/M) and Tumor-to-Skin (T/S) ratios of redaporfin at various DLIs obtained from C57BL/6J mice bearing LLC tumors.

	DLI = 15 min	DLI = 3 h	DLI = 72 h
T:M	1.68	0.74	0.75
T:S	0.69	0.60	0.18